In a significant legislative push, Florida lawmakers are actively working to reshape the state’s cannabis framework—focusing on reducing costs for medical marijuana patients and implementing stricter regulations on hemp-derived products.
Medical Marijuana: Reducing Costs for Patients
One of the most patient-focused proposals under discussion is extending the renewal period for Florida’s medical marijuana ID cards from one year to two. Additionally, the $75 renewal fee would be waived for military veterans. State Representative Michelle Salzman (R-Cantonment) said these changes are intended to offer much-needed relief, particularly for patients on fixed incomes or those using cannabis to manage chronic conditions.
Jodi James, a long-standing advocate with the Florida Cannabis Action Network, supported the effort, noting how the proposal could benefit patients across income levels. However, she also voiced concern that some of the proposed hemp-related legislation could inadvertently raise prices on alternative cannabinoid products that many residents rely on for affordability.
Hemp Regulations: Taxes and Retail Restrictions
At the heart of the hemp debate are two bills—HB 7027 and HB 7029—that would introduce a 15% excise tax on hemp-derived THC products, such as those containing Delta-8 and Delta-9. Lawmakers argue that this tax revenue would help fund oversight, product testing, and public health measures. The first $6 million collected annually would be allocated to Florida’s Department of Agriculture and Consumer Services to enforce new standards.
The legislation would also bar individuals under the age of 21 from entering stores selling hemp-derived THC products. Retailers would be required to hold a food permit from the state, a measure that could restrict sales in convenience stores and gas stations. Some lawmakers are pushing for broader retailer inclusion to avoid negative economic impacts on small businesses.
Senate Bill 438: Banning Delta-8 and Capping THC
In the Senate, SB 438 proposes sweeping restrictions on the hemp industry, including a full ban on Delta-8 THC and limits on Delta-9 THC in hemp-derived products—capping it at 5 milligrams per serving or 50 milligrams per package. THC-infused beverages would be restricted to 5 milligrams per container and could only be sold by retailers with liquor licenses.
These regulations also introduce new product testing requirements, mandating lab testing and labeling protocols for any product containing hemp extract. Senator Colleen Burton (R-Lakeland), who introduced the bill, cited a 50% increase in deaths from synthetic cannabinoids between 2022 and 2023 as a key reason for increased oversight.
Industry Pushback and Public Debate
Industry advocates have warned that these sweeping changes—particularly the taxation and bans—could cripple small hemp businesses and severely limit consumer access to popular products. Business owners and entrepreneurs testified that increased costs and fewer retail options may force closures or job cuts statewide.
These discussions come in the wake of Florida voters rejecting Amendment 3 in November 2024, a proposed constitutional amendment that would have legalized recreational marijuana. While the measure earned 56% of the vote, it fell short of the 60% supermajority required for passage.
As the 2025 legislative session continues, Florida’s approach to cannabis remains in flux. Lawmakers face the delicate challenge of protecting public health while sustaining an industry that supports thousands of jobs and provides medical relief for tens of thousands of residents.